|
GATC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.39000000188139E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.459400E-03 |
| Normal-vs-Stage2 |
6.46570000000235E-05 |
| Normal-vs-Stage3 |
9.56879997460192E-09 |
| Normal-vs-Stage4 |
8.61079999525671E-08 |
| Stage1-vs-Stage2 |
4.824300E-02 |
| Stage1-vs-Stage3 |
1.764610E-04 |
| Stage1-vs-Stage4 |
6.032100E-04 |
| Stage2-vs-Stage3 |
3.969400E-01 |
| Stage2-vs-Stage4 |
3.675200E-01 |
| Stage3-vs-Stage4 |
9.444800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.93339999752385E-08 |
| Normal-vs-AfricanAmerican |
1.648880E-04 |
| Normal-vs-Asian |
3.636600E-01 |
| Caucasian-vs-AfricanAmerican |
5.593400E-01 |
| Caucasian-vs-Asian |
4.617800E-02 |
| AfricanAmerican-vs-Asian |
2.765900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39939999588279E-08 |
| Normal-vs-Female |
2.016500E-04 |
| Male-vs-Female |
9.910300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.141830E-02 |
| Normal-vs-Age(41-60Yrs) |
4.2131999999917E-06 |
| Normal-vs-Age(61-80Yrs) |
6.64069999989358E-07 |
| Normal-vs-Age(81-100Yrs) |
4.12260000000053E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.581800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.340200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.632200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.070800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.710800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.014000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.517600E-01 |
| Normal-vs-Grade 2 |
9.7122000000005E-05 |
| Normal-vs-Grade 3 |
4.74929999993989E-07 |
| Normal-vs-Grade 4 |
6.24969997975455E-09 |
| Grade 1-vs-Grade 2 |
2.455800E-01 |
| Grade 1-vs-Grade 3 |
1.261810E-01 |
| Grade 1-vs-Grade 4 |
9.222000E-03 |
| Grade 2-vs-Grade 3 |
1.473450E-01 |
| Grade 2-vs-Grade 4 |
2.338600E-03 |
| Grade 3-vs-Grade 4 |
7.765900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.165200E-04 |
| Normal-vs-ccB subtype |
2.08020000003195E-07 |
| ccA subtype-vs-ccB subtype |
5.644100E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94539999998078E-06 |
| Normal-vs-N1 |
3.827900E-02 |
| N0-vs-N1 |
4.753200E-01 |
|
|
